HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Kotowicz Selected Research

Mark A Kotowicz Research Topics

Disease

19Osteoporosis
01/2020 - 03/2002
5Bone Resorption
01/2018 - 01/2004
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2019
2Hypothyroidism
09/2021 - 09/2005
2Frailty
01/2021 - 09/2020
2Inflammation (Inflammations)
01/2021 - 11/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 01/2019
2Chronic Disease (Chronic Diseases)
06/2019 - 11/2017
2Breast Neoplasms (Breast Cancer)
01/2019 - 01/2018
2Knee Osteoarthritis
01/2018 - 11/2017
2Osteoarthritis
11/2017 - 04/2012
2Cognitive Dysfunction
06/2014 - 10/2013
2Major Depressive Disorder (Major Depressive Disorders)
06/2012 - 11/2010
2Hypertension (High Blood Pressure)
06/2009 - 01/2007
1Wounds and Injuries (Trauma)
11/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2020
1Kidney Diseases (Kidney Disease)
01/2020
1Osteoporotic Fractures
01/2020
1Albuminuria
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
07/2019
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2019
1Pain (Aches)
01/2019
1Osteitis Deformans (Paget's Disease of Bone)
01/2019
1Diabetic Retinopathy (Retinopathy, Diabetic)
12/2018
1Metabolic Bone Diseases (Osteopenia)
06/2017
1Critical Illness (Critically Ill)
01/2017
1Obesity
01/2015
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
10/2013
1Osteophyte
06/2012
1Depressive Disorder (Melancholia)
04/2008
1Mental Disorders (Mental Disorder)
09/2005
1Delirium
09/2005
1Wrist Fractures
05/2004
1Cleidocranial Dysplasia (Cleidocranial Dysostosis)
08/2002

Drug/Important Bio-Agent (IBA)

5CalciumIBA
11/2020 - 03/2009
5Vitamin DFDA LinkGeneric
11/2020 - 05/2004
4Diphosphonates (Bisphosphonates)IBA
01/2020 - 01/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
09/2020 - 01/2018
3AntioxidantsIBA
09/2020 - 04/2006
3Hormones (Hormone)IBA
01/2020 - 06/2004
2Thyroxine (Levothyroxine)FDA LinkGeneric
09/2021 - 09/2005
2DenosumabFDA Link
01/2020 - 01/2019
2MineralsIBA
01/2018 - 03/2009
2Metformin (Glucophage)FDA LinkGeneric
06/2014 - 10/2013
2hydroxide ionIBA
06/2012 - 05/2004
2Parathyroid Hormone (Parathormone)IBA
06/2009 - 05/2004
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
09/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020
1setanaxibIBA
01/2020
1Raloxifene Hydrochloride (Evista)FDA Link
01/2020
1AlbuminsIBA
01/2020
1StrontiumIBA
01/2020
1Zoledronic Acid (Zometa)FDA Link
01/2019
1Sodium-Glucose Transport ProteinsIBA
01/2019
1Aromatase InhibitorsIBA
01/2019
1insulin receptor-related receptor (IRR)IBA
01/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019
1collagen type I trimeric cross-linked peptideIBA
01/2018
1ProcollagenIBA
01/2018
1GlucocorticoidsIBA
01/2017
1HDL CholesterolIBA
01/2015
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2013
1SeleniumIBA
06/2012
1Acetaminophen (Paracetamol)FDA LinkGeneric
06/2011
1C-Reactive ProteinIBA
11/2010
125-hydroxyvitamin DIBA
06/2009
1LeptinIBA
04/2008
1Acetylcysteine (Siran)FDA LinkGeneric
10/2007
1CholesterolIBA
01/2007
1Pharmaceutical PreparationsIBA
05/2006
1Vitamin EFDA LinkGeneric
04/2006
1Thyroid HormonesIBA
09/2005
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
01/2004
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2004
1Glutamine (L-Glutamine)FDA Link
08/2002
1Alanine (L-Alanine)FDA Link
08/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2002

Therapy/Procedure

8Therapeutics
01/2020 - 06/2004
4Replacement Arthroplasty
06/2019 - 04/2012
1Patient Readmission
07/2019
1Ambulatory Care (Outpatient Care)
12/2018
1Knee Replacement Arthroplasty (Total Knee Replacement)
11/2017
1Hip Replacement Arthroplasty (Total Hip Replacement)
11/2017
1Polypharmacy
06/2017
1Drug Therapy (Chemotherapy)
01/2012
1Duration of Therapy
01/2012
1Inappropriate Prescribing
09/2009